Correlation Between Ascletis Pharma and NLS Pharmaceutics
Can any of the company-specific risk be diversified away by investing in both Ascletis Pharma and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ascletis Pharma and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ascletis Pharma and NLS Pharmaceutics AG, you can compare the effects of market volatilities on Ascletis Pharma and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ascletis Pharma with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ascletis Pharma and NLS Pharmaceutics.
Diversification Opportunities for Ascletis Pharma and NLS Pharmaceutics
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Ascletis and NLS is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Ascletis Pharma and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and Ascletis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ascletis Pharma are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of Ascletis Pharma i.e., Ascletis Pharma and NLS Pharmaceutics go up and down completely randomly.
Pair Corralation between Ascletis Pharma and NLS Pharmaceutics
Assuming the 90 days horizon Ascletis Pharma is expected to generate 4.26 times less return on investment than NLS Pharmaceutics. But when comparing it to its historical volatility, Ascletis Pharma is 2.86 times less risky than NLS Pharmaceutics. It trades about 0.06 of its potential returns per unit of risk. NLS Pharmaceutics AG is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 13.00 in NLS Pharmaceutics AG on December 2, 2024 and sell it today you would lose (11.80) from holding NLS Pharmaceutics AG or give up 90.77% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 98.67% |
| Values | Daily Returns |
Ascletis Pharma vs. NLS Pharmaceutics AG
Performance |
| Timeline |
| Ascletis Pharma |
| NLS Pharmaceutics |
Ascletis Pharma and NLS Pharmaceutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ascletis Pharma and NLS Pharmaceutics
The main advantage of trading using opposite Ascletis Pharma and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ascletis Pharma position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.The idea behind Ascletis Pharma and NLS Pharmaceutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| NLS Pharmaceutics vs. Reviva Pharmaceuticals Holdings | NLS Pharmaceutics vs. GeoVax Labs | NLS Pharmaceutics vs. NLS Pharmaceutics AG | NLS Pharmaceutics vs. Lixte Biotechnology Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |